360 related articles for article (PubMed ID: 31899397)
1. T2 Fluid-Attenuated Inversion Recovery Resection for Glioblastoma Involving Eloquent Brain Areas Facilitated Through Awake Craniotomy and Clinical Outcome.
Lu M; Fu ZH; He XJ; Lu JK; Deng XQ; Lin DL; Gu YM; Fan YF; Lai MY; Li J; Yang MM; Chen ZP
World Neurosurg; 2020 Mar; 135():e738-e747. PubMed ID: 31899397
[TBL] [Abstract][Full Text] [Related]
2. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
[TBL] [Abstract][Full Text] [Related]
3. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
4. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
5. What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?
Clavreul A; Aubin G; Delion M; Lemée JM; Ter Minassian A; Menei P
J Neurooncol; 2021 Jan; 151(2):113-121. PubMed ID: 33394262
[TBL] [Abstract][Full Text] [Related]
6. The Merits of Awake Craniotomy for Glioblastoma in the Left Hemispheric Eloquent Area: One Institution Experience.
Li YC; Chiu HY; Lin YJ; Chen KT; Hsu PW; Huang YC; Chen PY; Wei KC
Clin Neurol Neurosurg; 2021 Jan; 200():106343. PubMed ID: 33158628
[TBL] [Abstract][Full Text] [Related]
7. Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.
Di L; Shah AH; Mahavadi A; Eichberg DG; Reddy R; Sanjurjo AD; Morell AA; Lu VM; Ampie L; Luther EM; Komotar RJ; Ivan ME
J Neurosurg; 2023 Jan; 138(1):62-69. PubMed ID: 35623362
[TBL] [Abstract][Full Text] [Related]
8. Impact of removed tumor volume and location on patient outcome in glioblastoma.
Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
[TBL] [Abstract][Full Text] [Related]
9. The extent of resection of T2-flair hyperintense area for eloquent glioblastomas: outcomes analysis between awake and general anesthesia patients.
Curzi C; Giordan E; Guerriero A; Bendini M; Canova G; Feletti A; Marton E
J Neurosurg Sci; 2023 Aug; 67(4):480-490. PubMed ID: 34114434
[TBL] [Abstract][Full Text] [Related]
10. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
11. Surgical benefits of combined awake craniotomy and intraoperative magnetic resonance imaging for gliomas associated with eloquent areas.
Motomura K; Natsume A; Iijima K; Kuramitsu S; Fujii M; Yamamoto T; Maesawa S; Sugiura J; Wakabayashi T
J Neurosurg; 2017 Oct; 127(4):790-797. PubMed ID: 28059650
[TBL] [Abstract][Full Text] [Related]
12. Contribution of combined intraoperative electrophysiological investigation with 3-T intraoperative MRI for awake cerebral glioma surgery: comprehensive review of the clinical implications and radiological outcomes.
Ghinda D; Zhang N; Lu J; Yao CJ; Yuan S; Wu JS
Neurosurg Focus; 2016 Mar; 40(3):E14. PubMed ID: 26926054
[TBL] [Abstract][Full Text] [Related]
13. Impact of awake mapping on overall survival and extent of resection in patients with adult diffuse gliomas within or near eloquent areas: a retrospective propensity score-matched analysis of awake craniotomy vs. general anesthesia.
Fukui A; Muragaki Y; Saito T; Nitta M; Tsuzuki S; Asano H; Kawamata T
Acta Neurochir (Wien); 2022 Feb; 164(2):395-404. PubMed ID: 34605985
[TBL] [Abstract][Full Text] [Related]
14. Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study.
Gerritsen JKW; Zwarthoed RH; Kilgallon JL; Nawabi NL; Jessurun CAC; Versyck G; Pruijn KP; Fisher FL; Larivière E; Solie L; Mekary RA; Satoer DD; Schouten JW; Bos EM; Kloet A; Nandoe Tewarie R; Smith TR; Dirven CMF; De Vleeschouwer S; Broekman MLD; Vincent AJPE
Lancet Oncol; 2022 Jun; 23(6):802-817. PubMed ID: 35569489
[TBL] [Abstract][Full Text] [Related]
15. The SAFE-trial: Safe surgery for glioblastoma multiforme: Awake craniotomy versus surgery under general anesthesia. Study protocol for a multicenter prospective randomized controlled trial.
Gerritsen JKW; Klimek M; Dirven CMF; Hoop EO; Wagemakers M; Rutten GJM; Kloet A; Hallaert GG; Vincent AJPE
Contemp Clin Trials; 2020 Jan; 88():105876. PubMed ID: 31676314
[TBL] [Abstract][Full Text] [Related]
16. Extending the resection beyond the contrast-enhancement for glioblastoma: feasibility, efficacy, and outcomes.
Mampre D; Ehresman J; Pinilla-Monsalve G; Osorio MAG; Olivi A; Quinones-Hinojosa A; Chaichana KL
Br J Neurosurg; 2018 Oct; 32(5):528-535. PubMed ID: 30073866
[TBL] [Abstract][Full Text] [Related]
17. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
Coburger J; Hagel V; Wirtz CR; König R
PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
[TBL] [Abstract][Full Text] [Related]
18. Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme.
Höhne J; Schebesch KM; de Laurentis C; Akçakaya MO; Pedersen CB; Brawanski A; Poulsen FR; Kiris T; Cavallo C; Broggi M; Ferroli P; Acerbi F
World Neurosurg; 2019 May; 125():e158-e164. PubMed ID: 30682505
[TBL] [Abstract][Full Text] [Related]
19. Awake craniotomy versus craniotomy under general anesthesia without surgery adjuncts for supratentorial glioblastoma in eloquent areas: a retrospective matched case-control study.
Gerritsen JKW; Viëtor CL; Rizopoulos D; Schouten JW; Klimek M; Dirven CMF; Vincent AJE
Acta Neurochir (Wien); 2019 Feb; 161(2):307-315. PubMed ID: 30617715
[TBL] [Abstract][Full Text] [Related]
20. The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
Goldman DA; Hovinga K; Reiner AS; Esquenazi Y; Tabar V; Panageas KS
J Neurosurg; 2018 Nov; 129(5):1231-1239. PubMed ID: 29303449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
